166 related articles for article (PubMed ID: 7603057)
1. Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs.
Simpson KW; Stepien RL; Elwood CM; Boswood A; Vaillant CR
J Small Anim Pract; 1995 Apr; 36(4):161-5. PubMed ID: 7603057
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
Glaser B; Rösler A; Halperin Y
Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
[TBL] [Abstract][Full Text] [Related]
3. Effect of octreotide on plasma concentrations of glucose, insulin, glucagon, growth hormone, and cortisol in healthy dogs and dogs with insulinoma.
Robben JH; van den Brom WE; Mol JA; van Haeften TW; Rijnberk A
Res Vet Sci; 2006 Feb; 80(1):25-32. PubMed ID: 15946716
[TBL] [Abstract][Full Text] [Related]
4. No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma.
Timmer R; Koningsberger JC; Erkelens DW; Thijssen JH; Lips CJ; Koppeschaar HP
Neth J Med; 1991 Jun; 38(5-6):199-203. PubMed ID: 1922592
[TBL] [Abstract][Full Text] [Related]
5. Insulin-secreting tumor: diagnosis and medical and surgical management in 55 dogs.
Leifer CE; Peterson ME; Matus RE
J Am Vet Med Assoc; 1986 Jan; 188(1):60-4. PubMed ID: 3003016
[TBL] [Abstract][Full Text] [Related]
6. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of insulinoma in the dog: a retrospective study and a new diagnostic procedure.
Siliart B; Stambouli F
J Small Anim Pract; 1996 Aug; 37(8):367-70. PubMed ID: 8872936
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of benign insulinoma using octreotide LAR: a case report.
Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
[TBL] [Abstract][Full Text] [Related]
9. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma.
Katabami T; Kato H; Shirai N; Naito S; Saito N
Endocr J; 2005 Oct; 52(5):629-34. PubMed ID: 16284444
[TBL] [Abstract][Full Text] [Related]
10. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients.
Kishikawa H; Okada Y; Hirose A; Tanikawa T; Kanda K; Tanaka Y
Endocr J; 2006 Feb; 53(1):79-85. PubMed ID: 16543676
[TBL] [Abstract][Full Text] [Related]
12. [Benign insulinoma. Efficacy of preoperative treatment for persistent hyperinsulinemia using a synthetic somatostatin analog].
Esposito V; Esposito D; Lo Iudice G; Rispoli C; Verrillo A; D'Alessandro B
Minerva Endocrinol; 1994 Mar; 19(1):33-7. PubMed ID: 8035768
[TBL] [Abstract][Full Text] [Related]
13. On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma.
Verschoor L; Uitterlinden P; Lamberts SW; Del Pozo E
Clin Endocrinol (Oxf); 1986 Nov; 25(5):555-60. PubMed ID: 2887309
[TBL] [Abstract][Full Text] [Related]
14. Persistent hyperinsulinaemic hypoglycaemia of infancy: long-term treatment with the somatostatin analogue Sandostatin.
Glaser B; Landau H; Smilovici A; Nesher R
Clin Endocrinol (Oxf); 1989 Jul; 31(1):71-80. PubMed ID: 2688998
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.
Altschul M; Simpson KW; Dykes NL; Mauldin EA; Reubi JC; Cummings JF
J Small Anim Pract; 1997 Jul; 38(7):286-91. PubMed ID: 9239629
[TBL] [Abstract][Full Text] [Related]
16. Diazoxide treatment of canine insulinoma.
Parker AJ; Musselman EM; O'Brien D
Vet Rec; 1981 Aug; 109(9):178-9. PubMed ID: 6275601
[No Abstract] [Full Text] [Related]
17. Glucose-responsive and octreotide-sensitive insulinoma.
Izumiyama H; Gotyo N; Fukai N; Ozawa N; Doi M; Yoshimoto T; Arii S; Hirata Y
Intern Med; 2006; 45(8):519-24. PubMed ID: 16702744
[TBL] [Abstract][Full Text] [Related]
18. It's time to unamend the insulin-glucose ratio.
Edwards DF
J Am Vet Med Assoc; 1986 May; 188(9):951-3. PubMed ID: 3011720
[No Abstract] [Full Text] [Related]
19. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
[TBL] [Abstract][Full Text] [Related]
20. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
Alberts AS; Falkson G
S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
